ClinicalTrials.Veeva

Menu

Application of Circulating Exosomes in Early Diagnosis and Prognosis Evaluation After Intracerebral Hemorrhage

T

Tang-Du Hospital

Status

Unknown

Conditions

Intracerebral Hemorrhage;Circulating Exosomes

Study type

Observational

Funder types

Other

Identifiers

NCT05035134
TDSJWKICHEX

Details and patient eligibility

About

The purpose of this study is to observe the relationship between the changes of circulating exosomes and the development and outcome of the disease in patients with intracerebral hemorrhage, and to search for early serum markers and potential intervention targets for disease monitoring in patients with intracerebral hemorrhage

Enrollment

300 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. No systematic treatment was given before admission;
  2. The patients were diagnosed with cerebral hemorrhage, and had imaging evidence;
  3. The age was more than 18 years old;
  4. The patient or family member agrees to sign the informed consent.

Exclusion criteria

  1. Hematoma is caused by secondary factors (intracranial tumor, arteriovenous malformation or aneurysm);
  2. Bleeding into the ventricle;
  3. Multiple cerebral hemorrhage;
  4. The patient did not receive treatment in our hospital;
  5. Severe disability, dementia, or organ dysfunction before onset
  6. Coagulopathy or long-term use of anticoagulants
  7. Hematoma affects brain stem
  8. Subjects refused to participate

Trial contacts and locations

1

Loading...

Central trial contact

Xun Wu, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems